Cargando…
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas
Post-transplant lymphoproliferative disorders (PTLD) are iatrogenic immune deficiency-associated lymphoid/plasmacytic proliferations developing due to immunosuppression in solid organ or hematopoietic stem cell allograft patients. PTLD are characterized by abnormal proliferation of lymphoid cells an...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620595/ https://www.ncbi.nlm.nih.gov/pubmed/37259566 http://dx.doi.org/10.3324/haematol.2023.282831 |
_version_ | 1785130240152961024 |
---|---|
author | Leivonen, Suvi-Katri Friman, Terhi Autio, Matias Vaittinen, Samuli Jensen, Andreas Wind d’Amore, Francesco Hamilton-Dutoit, Stephen Jacques Holte, Harald Beiske, Klaus Kovanen, Panu E. Räty, Riikka Leppä, Sirpa |
author_facet | Leivonen, Suvi-Katri Friman, Terhi Autio, Matias Vaittinen, Samuli Jensen, Andreas Wind d’Amore, Francesco Hamilton-Dutoit, Stephen Jacques Holte, Harald Beiske, Klaus Kovanen, Panu E. Räty, Riikka Leppä, Sirpa |
author_sort | Leivonen, Suvi-Katri |
collection | PubMed |
description | Post-transplant lymphoproliferative disorders (PTLD) are iatrogenic immune deficiency-associated lymphoid/plasmacytic proliferations developing due to immunosuppression in solid organ or hematopoietic stem cell allograft patients. PTLD are characterized by abnormal proliferation of lymphoid cells and have a heterogeneous clinical behavior. We profiled expression of >700 tumor microenvironment (TME)-related genes in 75 post-transplant aggressive B-cell lymphomas (PT-ABCL). Epstein-Barr virus (EBV)-positive PT-ABCL clustered together and were enriched for type I interferon pathway and antiviral-response genes. Additionally, a cytotoxicity gene signature associated with EBV-positivity and favorable overall survival (OS) (hazard ratio =0.61; P=0.019). In silico immunophenotyping revealed two subgroups with distinct immune cell compositions. The inflamed subgroup with higher proportions of immune cells had better outcome compared to non-inflamed subgroup (median OS >200.0 vs. 15.2 months; P=0.006). In multivariable analysis with EBV status, International Prognostic Index, and rituximab-containing treatment, inflamed TME remained as an independent predictor for favorable outcome. We also compared TME between post-transplant and immunocompetent host diffuse large B-cell lymphomas (n=75) and discovered that the proportions of T cells were lower in PT-diffuse large B-cell lymphomas. In conclusion, we provide a comprehensive phenotypic characterization of PT-ABCL, highlighting the importance of immune cell composition of TME in determining the clinical behavior and prognosis of PT-ABCL. |
format | Online Article Text |
id | pubmed-10620595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-106205952023-11-03 Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas Leivonen, Suvi-Katri Friman, Terhi Autio, Matias Vaittinen, Samuli Jensen, Andreas Wind d’Amore, Francesco Hamilton-Dutoit, Stephen Jacques Holte, Harald Beiske, Klaus Kovanen, Panu E. Räty, Riikka Leppä, Sirpa Haematologica Article - Non-Hodgkin Lymphoma Post-transplant lymphoproliferative disorders (PTLD) are iatrogenic immune deficiency-associated lymphoid/plasmacytic proliferations developing due to immunosuppression in solid organ or hematopoietic stem cell allograft patients. PTLD are characterized by abnormal proliferation of lymphoid cells and have a heterogeneous clinical behavior. We profiled expression of >700 tumor microenvironment (TME)-related genes in 75 post-transplant aggressive B-cell lymphomas (PT-ABCL). Epstein-Barr virus (EBV)-positive PT-ABCL clustered together and were enriched for type I interferon pathway and antiviral-response genes. Additionally, a cytotoxicity gene signature associated with EBV-positivity and favorable overall survival (OS) (hazard ratio =0.61; P=0.019). In silico immunophenotyping revealed two subgroups with distinct immune cell compositions. The inflamed subgroup with higher proportions of immune cells had better outcome compared to non-inflamed subgroup (median OS >200.0 vs. 15.2 months; P=0.006). In multivariable analysis with EBV status, International Prognostic Index, and rituximab-containing treatment, inflamed TME remained as an independent predictor for favorable outcome. We also compared TME between post-transplant and immunocompetent host diffuse large B-cell lymphomas (n=75) and discovered that the proportions of T cells were lower in PT-diffuse large B-cell lymphomas. In conclusion, we provide a comprehensive phenotypic characterization of PT-ABCL, highlighting the importance of immune cell composition of TME in determining the clinical behavior and prognosis of PT-ABCL. Fondazione Ferrata Storti 2023-06-01 /pmc/articles/PMC10620595/ /pubmed/37259566 http://dx.doi.org/10.3324/haematol.2023.282831 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article - Non-Hodgkin Lymphoma Leivonen, Suvi-Katri Friman, Terhi Autio, Matias Vaittinen, Samuli Jensen, Andreas Wind d’Amore, Francesco Hamilton-Dutoit, Stephen Jacques Holte, Harald Beiske, Klaus Kovanen, Panu E. Räty, Riikka Leppä, Sirpa Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas |
title | Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas |
title_full | Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas |
title_fullStr | Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas |
title_full_unstemmed | Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas |
title_short | Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas |
title_sort | characterization and clinical impact of the tumor microenvironment in post-transplant aggressive b-cell lymphomas |
topic | Article - Non-Hodgkin Lymphoma |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620595/ https://www.ncbi.nlm.nih.gov/pubmed/37259566 http://dx.doi.org/10.3324/haematol.2023.282831 |
work_keys_str_mv | AT leivonensuvikatri characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT frimanterhi characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT autiomatias characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT vaittinensamuli characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT jensenandreaswind characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT damorefrancesco characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT hamiltondutoitstephenjacques characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT holteharald characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT beiskeklaus characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT kovanenpanue characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT ratyriikka characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas AT leppasirpa characterizationandclinicalimpactofthetumormicroenvironmentinposttransplantaggressivebcelllymphomas |